Power of Innovation: The Bayh-Dole Coalition’s Role in American Progress

Shafiqul Islam Chowdhury

Professor of Molecular Virology at Louisiana State University, with a PhD from the Free University of Berlin. Specializes in the molecular and immunological mechanisms of Bovine Herpesvirus-1 (BHV-1) pathogenesis. Develops innovative herpesvirus-vectored vaccines for cattle and swine diseases, including BRDC, Rift Valley Fever, and African swine fever.

Dr. Chowdhury was recognized with numerous awards, including the National Academy of Inventors Senior Member, Zoetis Award and Pfizer Award for Research Excellence.

Chowdhury’s innovative vaccine platform, now licensed to the South Dakota startup RTI, represents a major advancement in animal health with implications for humans as well. The vaccine, currently undergoing tests in pregnant cattle, is projected to prevent the loss of 8 million calves annually, saving the U.S. cattle industry an estimated $1 billion. Beyond its immediate impact, the platform’s versatility could lead to the development of vaccines for multiple animal species and a variety of diseases.

This innovation is significant not only for animal welfare but also for human health, as preventing the spread of diseases among animals reduces the risk of viral mutations that could cross over to humans. Viruses like HIV and dengue are examples of this zoonotic transmission.

Through the Bayh-Dole Act, Chowdhury’s research was able to be patented and licensed, showcasing how public-private partnerships can drive innovations from the lab to the market.